To view this email as a web page, click here.
 
 
SGLT2 Inhibitors Improve HF, Survival in Clinical T2D Population
ACC 2017: Findings from REAL-CVD study suggest cardioprotection is class effect.
What impact on prescribing?
 
ECG Challenge: Weak, Dry, and Sick
A 72-year-old woman has progressive weakness, dyspnea, decreased oral intake, and feels "sick."
ACS or something else?
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.